Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kiran Malikayil"'
Publikováno v:
IDCases, Vol 25, Iss , Pp e01201- (2021)
Infective endocarditis (IE) is a persistent health issue, particularly among intravenous drug users. We discussed a case of infective endocarditis in a patient who uses IV drugs, which had some unusual features such as unusual presentation, polymicro
Externí odkaz:
https://doaj.org/article/de0117b7c5d9464a9de4b81119b35002
Autor:
Anna E. Vilgelm, Priscilla Cobb, Kiran Malikayil, David Flaherty, C. Andrew Johnson, Dayanidhi Raman, Nabil Saleh, Brian Higgins, Brandon A. Vara, Jeffrey N. Johnston, Douglas B. Johnson, Mark C. Kelley, Sheau-Chiann Chen, Gregory D. Ayers, Ann Richmond
Publikováno v:
EBioMedicine, Vol 24, Iss C, Pp 43-55 (2017)
Antagonists of MDM2-p53 interaction are emerging anti-cancer drugs utilized in clinical trials for malignancies that rarely mutate p53, including melanoma. We discovered that MDM2-p53 antagonists protect DNA from drug-induced damage in melanoma cells
Externí odkaz:
https://doaj.org/article/2c72f0bce0994f99b7abe6f544b4d5e2
Autor:
Rachel Jane Klapper, Benjamin Joseph Michael Horn, Benedict Amalraj, Maamannan Venkataraj, Mohammad Abdurrehman Sheikh, Dominika Pullmann, Kiran Malikayil, Jeffrey Wooliscroft
Publikováno v:
BJR|case reports. 9
Necrotizing fasciitis of the breast is a rare, life-threatening entity characterized by a rapidly aggressive infection of the soft tissue. There are few literature reports on necrotizing fasciitis at the level of the breast tissue as the most common
Publikováno v:
Curr Probl Diagn Radiol
The delineation and characterization of splenic lesions and other abnormalities can be challenging on computed tomography. Many splenic lesions are incidentally found, imaging features tend to overlap, and without the appropriate clinical context, di
Autor:
Brian Higgins, Nabil Saleh, Anna E. Vilgelm, Mark C. Kelley, Brandon A. Vara, Gregory D. Ayers, Sheau-Chiann Chen, Kiran Malikayil, David K. Flaherty, Dayanidhi Raman, Ann Richmond, Douglas B. Johnson, Priscilla Cobb, Jeffrey N. Johnston, C. Andrew Johnson
Publikováno v:
EBioMedicine
EBioMedicine, Vol 24, Iss C, Pp 43-55 (2017)
EBioMedicine, Vol 24, Iss C, Pp 43-55 (2017)
Antagonists of MDM2-p53 interaction are emerging anti-cancer drugs utilized in clinical trials for malignancies that rarely mutate p53, including melanoma. We discovered that MDM2-p53 antagonists protect DNA from drug-induced damage in melanoma cells
Autor:
Kiran Malikayil, Ann Richmond, David K. Flaherty, Brian Higgins, Dayanidhi Raman, C. Andrew Johnson, Anna E. Vilgelm
Publikováno v:
Cancer Research. 77:513-513
Genomic instability is a hallmark of cancer implicated in tumor evolution and resistance to therapy. However, the molecular mechanisms that underlie genomic instability are still poorly understood. One common feature of cancer cells is an elevated ge